MIA MAIOLATESI: Open Payments
NPI 1639957822 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,388 in 206 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $3,100 · 2025 $3,388
Food & beverage: $3,309Education: $80
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $486 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $470 |
| ABBVIE INC. | 34 | $402 |
| Janssen Pharmaceuticals, Inc | 26 | $394 |
| Neurocrine BioSciences, Inc. | 24 | $319 |
| Alkermes, Inc. | 16 | $315 |
| Axsome Therapeutics, Inc. | 8 | $218 |
| Vanda Pharmaceuticals Inc. | 7 | $176 |
| E.R. Squibb & Sons, L.L.C. | 12 | $162 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, INGREZZA, ARISTADA, INVEGA SUSTENNA, Auvelity, FANAPT.
Industry payments across PA — which companies pay providers there.
